Claudio Sole Pešutić

29 posts

Claudio Sole Pešutić banner
Claudio Sole Pešutić

Claudio Sole Pešutić

@PesuticSole

Director Clínica IRAM. Medico Radio-Oncólogo; casado, padre de 3. PhD en Ciencias Biomédicas; Profesor UDP

Katılım Nisan 2017
981 Takip Edilen237 Takipçiler
@Enel_Informa_CL
@Enel_Informa_CL@Enel_Informa_CL·
@PesuticSole Hola Claudio, para poder ayudarte, por favor indícanos la calle/esquina de la cual nos reportas la falta de suministro. Quedamos a la Espera.
Español
1
0
0
0
@Enel_Informa_CL
@Enel_Informa_CL@Enel_Informa_CL·
[06:08] El mapa muestra #CorteDeEnergía en el sector desde Camino El Alba hasta Av. las Condes en la comuna Las Condes, informamos que un 84% clientes inicialmente afectados ya cuenta con suministro eléctrico. Envíanos #LUZ por mensaje interno para poder realizar un reporte.
@Enel_Informa_CL tweet media@Enel_Informa_CL tweet media
Español
18
0
0
0
José Peña
José Peña@PenaDuranJose·
@ffquezad @NEJM Don't you ever rest Dr. Quezada? It's the middle of the weekend!!!
English
1
0
2
0
Claudio Sole Pešutić retweetledi
Stephen V Liu, MD
Stephen V Liu, MD@StephenVLiu·
#ESMO20 Practice changing data presented by Dr. Cecile Le Pechoux @GustaveRoussy. The prospective, randomized phase III LUNG-ART study explores the benefit of post-operative radiotherapy for completely resected #NSCLC: no OS benefit seen. #LCSM @OncoAlert
Stephen V Liu, MD tweet media
English
5
31
63
0
Henning Willers, MD, FASTRO
Henning Willers, MD, FASTRO@HenningWillers·
@PesuticSole @finn_corinne @RT_physics @KathrynBanfill There are differences between countries and centers. In the US, about half of cN2 (single station) are treated with neoadjuvant chemoradiation. I doubt LungART can inform management of N2 after induction chemo. Different patient population. And also, future is induction IO? 🤔
Massachusetts, USA 🇺🇸 English
1
0
5
0
Corinne Faivre-Finn
Corinne Faivre-Finn@finn_corinne·
Not totally surprising @HenningWillers take a look at the causes of deaths (excess cardiopulmonary deaths) and second primary cancers in PORT group. This reinforces the importance of research to assess the impact of thoracic radiotherapy on the heart @RT_physics @KathrynBanfill
Henning Willers, MD, FASTRO@HenningWillers

LungART trial finally out at #ESMO20. Postop #radiotherapy with no significant benefit. Mediastinal recurrence of 46% without PORT was what would be expected & PORT decreased it but (I must say surprisingly) did not translate into DFS or OS benefit @PercyLeeMD @KHigginsMD #lcsm

English
3
6
34
0
Claudio Sole Pešutić
Claudio Sole Pešutić@PesuticSole·
@BenjaminBesseMD As is often the case when studies are published they do not represent current practice. The vast majority of cN2 patients are treated with neoadjuvant chemo followed by surgery. How does LungART results change clinical practice in ypN2 patients? To RT or not that is the question
Las Condes, Chile 🇨🇱 English
0
1
1
0
Benjamin Besse
Benjamin Besse@BenjaminBesseMD·
THANK YOU my dear colleague Cécile Le Pechoux: you bravely answered a very frequent tumor board question: in 2020, adjuvant RT is not standard of care in resected N2 NSCLC. Some said PACIFIC was THE SoC in stage III-N2 NSCLC but look at OS, surgery is not dead! #ESMO20 #LCSM
Benjamin Besse tweet media
English
4
48
133
0
Claudio Sole Pešutić
Claudio Sole Pešutić@PesuticSole·
As is often the case when studies are published they do not represent current practice. The vast majority of cN2 patients are treated with neoadjuvant chemo followed by surgery. How does LungART results change clinical practice in ypN2 patients? To RT or not that is the question
Las Condes, Chile 🇨🇱 English
1
1
2
0
José Peña
José Peña@PenaDuranJose·
No faltan críticas a los hospitales cuando lo hacemos mal, pero trata vez sale en las noticias cuando lo hacemos bien. Acá, queremos hacer las cosas cada vez mejor... Les presento a una pequeña fracción del equipo del centro oncológico @SoterodelRio. Feliz 18!
José Peña tweet media
Español
22
117
850
0
Claudio Sole Pešutić retweetledi
Drew Moghanaki
Drew Moghanaki@DrewMoghanaki·
Today’s update on randomized trials investigating the life-prolonging value of SBRT for people with stage IV lung cancer. #ASCO20 #lcsm #radonc
Drew Moghanaki tweet mediaDrew Moghanaki tweet mediaDrew Moghanaki tweet mediaDrew Moghanaki tweet media
English
4
32
103
0
Melvin LK CHUA | FRCR, PhD, FASCO
Very pleased to share the results of our RCT on consolidation RT in metastatic NPC changing the paradigm of how we think of treating metastatic disease and altering disease trajectory! #nasopharyngealcarcinoma #radiotherapy #metastasis @JAMAOnc
JAMA Oncology@JAMAOnc

Randomised trial supporting consolidation RT in chemoresponsive NPC as the new SOC ja.ma/2OM8RVQ @DrMLChua #VisualAbstract #radiotherapy #nasopharyngealcarcinoma #metastasis

West Region, Singapore 🇸🇬 English
14
61
181
0
Claudio Sole Pešutić retweetledi
Lacort Medical
Lacort Medical@LacortMedical·
🔷Te invitamos a inscribirte Gratuitamente en los Webinars de VARIAN Webinars Latam en Radioterapia 🔷 La primera serie será desde Chile 🇨🇱 ✍️ Inscripción Gratuita: educa-med.com/cursos/landing…
Northam, England 🇬🇧 Español
0
2
3
0
Claudio Sole Pešutić retweetledi
Lacort Medical
Lacort Medical@LacortMedical·
►Te invitamos a inscribirte GRATUITAMENTE a los: LATAM CLINICAL WEBINAR - RADIOTERAPIA ☢️ El primer Webinar será lanzado el 2️⃣3️⃣ DE JULIO 2020. "SBRT Cáncer Pulmonar etapa precoz" LINK 👇 educa-med.com/cursos/landing… Los esperamos!!! #radioterapia @PesuticSole @SEBASOLE
Lacort Medical tweet media
Northam, England 🇬🇧 Español
0
3
5
0
Maarten van Smeden
Maarten van Smeden@MaartenvSmeden·
Why did you become a scientist? Wrong answers only
English
2.2K
331
2.3K
0
Ulrike Schick
Ulrike Schick@UliSchick·
Yesterday, my old co-resident @ZilliThomas was promoted to Professor of Radiation Oncology in Geneva @Hopitaux_unige Brilliant news, this is so well deserved !! (So sorry I missed his inaugural lecture) 🍾🤗
English
12
2
37
0